⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21840885 | 0.74 | — | — | |
| SCHEMBL11218833 | 0.70 | — | — | |
| SCHEMBL209652 | 0.70 | — | — | |
| SCHEMBL2364329 | 0.70 | — | — | |
| SCHEMBL297152 | 0.70 | — | — | |
| SCHEMBL7591167 | 0.70 | — | — | |
| SCHEMBL1270299 | 0.70 | — | — | |
| SCHEMBL12813492 | 0.70 | — | — | |
| SCHEMBL6067714 | 0.70 | — | — | |
| Isopropylamine SCHEMBL1193775 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5929103-A | ANTICARCINOGENIC AGENTS | DONG WHA PHARM. IND. CO., LTD. (KR) | 1999-07-27 | — | — | US | claimed |
| CN-112533887-A | Salts of diamino acetals and diamino ketals, their synthesis and their conversion to diamino acetals and diamino ketals | 阿迪蒂亚博拉化学品(美国)有限责任公司 | 2021-03-19 | — | — | CN | disclosed |
| US-10913790-B2 | Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2021-02-09 | — | — | US | disclosed |
| US-20200206328-A1 | COMPOSITIONS, METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR EARLY INTERVENTION IN BONE MARROW TRANSPLANTATION AND TREATMENT OF GRAFT VERSUS HOST DISEASE | UNIV COLORADO REGENTS (US) | 2020-07-02 | — | — | US | disclosed |
| US-20200079836-A1 | COMPOSITIONS OF, AND METHODS FOR, ALPHA-1 ANTI TRYPSIN Fc FUSION MOLECULES | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2020-03-12 | — | — | US | disclosed |
| CN-103492553-B | For producing the method for cadaverine and recombinant microorganism | 巴斯夫欧洲公司 | 2018-06-12 | — | — | CN | disclosed |
| US-20180133294-A1 | COMPOSITIONS AND METHODS RELATED TO GRAFT VERSUS HOST DISEASE AND TREATMENTS THEREOF | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2018-05-17 | — | — | US | disclosed |
| US-9884096-B2 | Compositions and methods related to graft versus host disease and treatments thereof | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2018-02-06 | — | — | US | disclosed |
| US-20170240615-A1 | COMPOSITIONS OF, AND METHODS FOR, ALPHA-1 ANTITRYPSIN Fc FUSION MOLECULES | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2017-08-24 | — | — | US | disclosed |
| EP-1909810-B2 | INHIBITORS OF SERINE PROTEASE ACTIVITY AND THEIR USE IN METHODS AND COMPOSITIONS FOR TREATMENT OF GRAFT REJECTION AND PROMOTION OF GRAFT SURVIVAL | UNIV COLORADO REGENTS (US) | 2017-08-23 | — | — | EP | disclosed |
| CN-1255119-A | Protease inhibitors | SMITHKLINE BEECHAM CORP (US) | 2000-05-31 | — | — | CN | disclosed |
| CN-1253552-A | Process for preparation of 1,4,7,10-tetraazacyclododecane | BRACCO SPA (IT) | 2000-05-17 | — | — | CN | disclosed |
| US-6057362-A | Protease inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0983228-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-03-08 | — | — | EP | disclosed |
| EP-0983228-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-03-08 | — | — | EP | disclosed |
| US-5998470-A | Protease inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1999-12-07 | — | — | US | disclosed |
| WO-1999059526-A2 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-11-25 | — | — | WO | disclosed |
| WO-1998050342-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998050342-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-11-12 | — | — | WO | disclosed |
| CN-1177293-A | Method for inhibiting cathepsin K | SMITHKLINE BEECHAM CORP (US) | 1998-03-25 | — | — | CN | disclosed |